Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1981 May;32(2):964–966. doi: 10.1128/iai.32.2.964-966.1981

Vibrio vulnificus (Lactose-Positive Vibrio) and Vibrio parahaemolyticus Differ in Their Susceptibilities to Human Serum

Mary M Carruthers 1, William J Kabat 1
PMCID: PMC351537  PMID: 6788703

Abstract

Eleven Vibrio vulnificus (lactose-positive vibrio) strains were less susceptible to the bactericidal activity of normal human serum or serum treated with magnesium-ethyleneglycol-bis (β-aminoethyl ether)-N,N′-tetraacetic acid than were six Vibrio parahaemolyticus strains.

Full text

PDF
964

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blake P. A., Merson M. H., Weaver R. E., Hollis D. G., Heublein P. C. Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med. 1979 Jan 4;300(1):1–5. doi: 10.1056/NEJM197901043000101. [DOI] [PubMed] [Google Scholar]
  2. Fierer J., Finley F. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver. J Clin Invest. 1979 May;63(5):912–921. doi: 10.1172/JCI109391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fine D. P., Marney S. R., Jr, Colley D. G., Sergent J. S., Des Prez R. M. C3 shunt activation in human serum chelated with EGTA. J Immunol. 1972 Oct;109(4):807–809. [PubMed] [Google Scholar]
  4. Ingwer I., Petersen B. H., Brooks G. Serum bactericidal action and activation of the classic and alternate complement pathways by Neisseria gonorrhoeae. J Lab Clin Med. 1978 Aug;92(2):211–220. [PubMed] [Google Scholar]
  5. MUSCHEL L. H., MUTO T. Bactericidal reaction of mouse serum. Science. 1956 Jan 13;123(3185):62–64. doi: 10.1126/science.123.3185.62. [DOI] [PubMed] [Google Scholar]
  6. Polhill R. B., Jr, Newman S. L., Pruitt K. M., Johnston R. B., Jr Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation. J Immunol. 1978 Jul;121(1):371–376. [PubMed] [Google Scholar]
  7. Poole M. D., Oliver J. D. Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactose-positive Vibrio sp. Infect Immun. 1978 Apr;20(1):126–129. doi: 10.1128/iai.20.1.126-129.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Roantree R. J., Rantz L. A. A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION. J Clin Invest. 1960 Jan;39(1):72–81. doi: 10.1172/JCI104029. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES